216 related articles for article (PubMed ID: 24124339)
1. Association between vitamin D and hepatitis C virus infection: a meta-analysis.
Villar LM; Del Campo JA; Ranchal I; Lampe E; Romero-Gomez M
World J Gastroenterol; 2013 Sep; 19(35):5917-24. PubMed ID: 24124339
[TBL] [Abstract][Full Text] [Related]
2. Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients.
Melo-Villar L; Lampe E; de Almeida AJ; de P Scalioni L; Lewis-Ximenez LL; Miguel JC; Del Campo JA; Ranchal I; Villela-Nogueira CA; Romero-Gomez M
Ann Hepatol; 2015; 14(4):457-63. PubMed ID: 26019031
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status and viral response to therapy in hepatitis C infected children.
Eltayeb AA; Abdou MA; Abdel-aal AM; Othman MH
World J Gastroenterol; 2015 Jan; 21(4):1284-91. PubMed ID: 25632203
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.
Kitson MT; Sarrazin C; Toniutto P; Eslick GD; Roberts SK
J Hepatol; 2014 Dec; 61(6):1247-52. PubMed ID: 25135863
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P
World J Gastroenterol; 2015 May; 21(18):5647-53. PubMed ID: 25987791
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients.
Nimer A; Mouch A
World J Gastroenterol; 2012 Feb; 18(8):800-5. PubMed ID: 22371640
[TBL] [Abstract][Full Text] [Related]
8. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
[TBL] [Abstract][Full Text] [Related]
9. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
[TBL] [Abstract][Full Text] [Related]
10. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.
Simmons B; Saleem J; Hill A; Riley RD; Cooke GS
Clin Infect Dis; 2016 Mar; 62(6):683-694. PubMed ID: 26787172
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
[TBL] [Abstract][Full Text] [Related]
12. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
[TBL] [Abstract][Full Text] [Related]
13. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
Nilsson J; Weiland O
Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
[TBL] [Abstract][Full Text] [Related]
14. Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.
Feng B; Zhang W; Luo BF; Song GJ; Wang J; Jin Q; Qin H; Wei L
World J Gastroenterol; 2014 Nov; 20(41):15387-97. PubMed ID: 25386089
[TBL] [Abstract][Full Text] [Related]
15. Sustained virological response according to the type of early virological response in HCV and HCV/HIV.
Lerias de Almeida PR; Alves de Mattos A; Valle Tovo C
Ann Hepatol; 2010; 9(2):150-5. PubMed ID: 20526007
[TBL] [Abstract][Full Text] [Related]
16. Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.
Peribañez-Gonzalez M; da Silva MH; Vilar FC; Seixas-Santos Nastri AC; Ferreira PA; Focaccia R; Mendes Correa MC
Ann Hepatol; 2013; 12(2):228-35. PubMed ID: 23396734
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
[TBL] [Abstract][Full Text] [Related]
18. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
20. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population.
Milazzo L; Mazzali C; Bestetti G; Longhi E; Foschi A; Viola A; Vago T; Galli M; Parravicini C; Antinori S
Curr HIV Res; 2011 Apr; 9(3):186-93. PubMed ID: 21585333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
